Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Leap Therapeutics Inc. buy Raymond James

Start price
14.11.23 / 50%
Target price
Performance (%)
This prediction is currently active. The BUY prediction by Raymond_James for Leap Therapeutics Inc. has seen massive gains of 82.48%. This prediction currently runs until 14.11.24. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this prediction
Performance without dividends (%)
Name 1w
Leap Therapeutics Inc. -7.634%
iShares Core DAX® 2.122%
iShares Nasdaq 100 1.636%
iShares Nikkei 225® -0.215%
iShares S&P 500 1.321%

Comments by Raymond_James for this prediction

In the thread Leap Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 82.48%
Target price 16.214
Ends at 14.11.24

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Raymond James from $18.50 to $17.50. They now have an "outperform" rating on the stock.
Ratings data for LPTX provided by MarketBeat